Delivery Order SPE2DB22D2206-SPE2DB24FFV85
Award Date
2/29/24
Potential Completion Date
3/1/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,230.98 Delivery Order contract is for the supply of Rexulti 2 mg tablets, a medication used to treat certain mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award, valued at $6,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rexulti 2 mg tablets, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award, with an ID of SPE2DX15D3001|SPE2DX24F4RE2, is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,061.15 firm fixed-price contract is for the delivery of 1 mg tablets of the medication Rexulti. The award has an ultimate completion date of February 15, 2024 and was made on February 14, 2024. This Delivery Order is part of a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Rexulti 2 mg tablets, a pharmaceutical product. The contract has a ceiling value of $6,020.46 and a performance period ending on August 24, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999 through December 2025. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,108.73 firm fixed-price delivery order contract is for the supply of Rexulti 1 mg tablets. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRJRK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Rexulti 1 mg tablets, a prescription medication, with a total ceiling value of $2,655.96 and a completion date of November 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,260.61 delivery order contract is for Rexulti 1 mg tablets and is a firm-fixed price contract type. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,199.87 delivery order contract is for the pharmaceutical product Rexulti 0.5 mg tablet, with a completion date of July 20, 2023. The contract was awarded on a firm fixed-price basis without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,446.50 firm-fixed-price delivery order is for the supply of the prescription medication Rexulti 2 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
This federal contract award, valued at $2,112.67, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of...